Physician profile
Susan E Brickle
NPI 1407876188
$1,182.39
in general payments reported to CMS, 2019-2025
20 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $202 · 2021: $180 · 2024: $182 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $562.32 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $87.02 | 2021 | |
| Amgen INC. | $81.60 | 2019-2021 | |
| Novo Nordisk INC | $71.96 | 2019-2021 | |
| Pfizer INC. | $59.78 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $44.04 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.03 | 2019 | |
| Allergan, INC. | $28.98 | 2020 | |
| Glaxosmithkline, LLC. | $23.21 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.93 | 2019-2020 | |
| Eisai INC. | $22.07 | 2020 | |
| Ironshore Pharmaceuticals INC. | $20.61 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $20.26 | 2021 | |
| Almatica Pharma LLC | $19.49 | 2021 | |
| Medtronic Vascular, INC. | $17.31 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $16.86 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.16 | 2020 | |
| Genentech USA, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Brickle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.